(NASDAQ: EMBC) Embecta's forecast annual revenue growth rate of 0.9% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 22.74%.
Embecta's revenue in 2025 is $1,080,400,000.On average, 6 Wall Street analysts forecast EMBC's revenue for 2026 to be $64,598,176,464, with the lowest EMBC revenue forecast at $61,848,072,937, and the highest EMBC revenue forecast at $66,646,125,899. On average, 6 Wall Street analysts forecast EMBC's revenue for 2027 to be $64,656,689,305, with the lowest EMBC revenue forecast at $62,082,124,301, and the highest EMBC revenue forecast at $66,646,125,899.
In 2028, EMBC is forecast to generate $65,007,766,351 in revenue, with the lowest revenue forecast at $62,433,201,347 and the highest revenue forecast at $66,880,177,263.